INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $74,000 | +42.3% | 13,320 | 0.0% | 0.01% | +37.5% |
Q2 2018 | $52,000 | -17.5% | 13,320 | 0.0% | 0.01% | -20.0% |
Q1 2018 | $63,000 | +14.5% | 13,320 | 0.0% | 0.01% | +11.1% |
Q4 2017 | $55,000 | -34.5% | 13,320 | 0.0% | 0.01% | -35.7% |
Q3 2017 | $84,000 | -19.2% | 13,320 | 0.0% | 0.01% | -22.2% |
Q2 2017 | $104,000 | +18.2% | 13,320 | 0.0% | 0.02% | +12.5% |
Q1 2017 | $88,000 | -4.3% | 13,320 | 0.0% | 0.02% | -11.1% |
Q4 2016 | $92,000 | -25.8% | 13,320 | 0.0% | 0.02% | -21.7% |
Q3 2016 | $124,000 | +0.8% | 13,320 | 0.0% | 0.02% | -4.2% |
Q2 2016 | $123,000 | +6.0% | 13,320 | 0.0% | 0.02% | +4.3% |
Q1 2016 | $116,000 | +28.9% | 13,320 | 0.0% | 0.02% | +27.8% |
Q4 2015 | $90,000 | +16.9% | 13,320 | 0.0% | 0.02% | +5.9% |
Q3 2015 | $77,000 | -29.4% | 13,320 | 0.0% | 0.02% | -26.1% |
Q2 2015 | $109,000 | 0.0% | 13,320 | 0.0% | 0.02% | +4.5% |
Q1 2015 | $109,000 | -10.7% | 13,320 | 0.0% | 0.02% | -4.3% |
Q4 2014 | $122,000 | -6.9% | 13,320 | 0.0% | 0.02% | -11.5% |
Q3 2014 | $131,000 | – | 13,320 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |